Life Science Sales Director, Luke Marshall from EMEA, provides his insight on the future of SPACs and how the process is still promising for biopharma companies to go public.
Blogs
Life Science Sales Director, Luke Marshall from EMEA, provides his insight on the future of SPACs and how the process is still promising for biopharma companies to go public.